logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Elie Traer

Oregon Health and Science University
H指数:34
被引数:8,717

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy in patients with myelofibrosis

1b期研究：ABBV-744（一种新型选择性BET抑制剂）作为单药疗法在骨髓纤维化患者中的应用

Blood Advances
IF7.1
2026-03-190
OAAI
John Mascarenhas; Laura Fogliatto; Steven Green; Ignacio Corvalan; Elie Traer; Keita Kirito; Hun Chuah; Kazuki Sakatoku; Rasmus Hoeg; Mohamad Khawandanah; David Lavie; Zoë Hunter; David Quinn; Yizhuo Wang; Jason Harb; Jiuhong Zha; Uriel Malyankar; Ellen Ritchie
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

新诊断急性髓系白血病60岁及以上患者的分子特征分析：Beat AML临床试验报告

BLOOD CANCER JOURNAL
IF11.6
2025-04-030
OA
Hoff, Fieke W.; Huang, Ying; Welkie, Rina Li; Swords, Ronan T.; Traer, Elie; Stein, Eytan M.; Lin, Tara L.; Patel, Prapti A.; Collins Jr, Robert H.; Baer, Maria R.; Duong, Vu H.; Blum, William G.; Arellano, Martha L.; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L.; Kovacsovics, Tibor; Deininger, Michael W.; Zeidner, Joshua F.; Olin, Rebecca L.; Smith, Catherine C.; Foran, James M.; Schiller, Gary J.; Curran, Emily K.; Koenig, Kristin L.; Heerema, Nyla A.; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G.; Rosenberg, Leonard; Druker, Brian J.; Levine, Ross L.; Burd, Amy; Yocum, Ashley O.; Borate, Uma M.; Mims, Alice S.; Byrd, John C.; Madanat, Yazan F.
PTPN11 Mutations Are Associated with Shorter Survival in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents and Venetoclax

PTPN11基因突变与接受表观遗传药物（包括低甲基化剂和Venetoclax）治疗的急性髓系白血病患者生存期缩短相关。

BLOOD
IF23.1
2024-11-050
PRE
Ravikumar, Vishvaas, I; Leonard, Jessica T.; Newell, Laura F.; Gandhi, Arpita; Meyers, Gabrielle; Hayes-Lattin, Brandon; Maziarz, Richard T.; Cook, Rachel J.; Traer, Elie; Swords, Ronan T.; Saultz, Jennifer N.; Tyner, Jeffrey W.; Heiblig, Mael; Zeidner, Joshua F.; Pollyea, Daniel A.; Lachowiez, Curtis A.
Impact of Social Determinants of Health on Access to Blood and Marrow Transplantation for Acute Myeloid Leukemia

社会决定因素对急性髓系白血病患者获得造血干细胞移植的影响

BLOOD
IF23.1
2024-11-050
PRE
Khare, Somya; Cook, Rachel J.; Desai, Amrita; Gandhi, Arpita; Goslee, Kelli; Hayes-Lattin, Brandon; Lachowiez, Curtis A.; Leonard, Jessica T.; Maziarz, Richard T.; Meyers, Gabrielle; Newell, Laura F.; Saultz, Jennifer N.; Swords, Ronan T.; Traer, Elie; Nemece, Eneida R.
IDH2 Mutation Is Associated with Favorable Outcome Among Older Adults with Newly Diagnosed Acute Myeloid Leukemia Treated with Lower-Intensity Therapy

IDH2突变与接受低强度治疗的新诊断急性髓系白血病老年患者的良好预后相关。

BLOOD
IF23.1
2024-11-051
PRE
Hoff, Fieke W.; Huang, Ying; Li Welkie, Rina; Swords, Ronan T.; Traer, Elie; Stein, Eytan M.; Lin, Tara L.; Patel, Prapti A.; Collins, Robert H.; Baer, Maria R.; Duong, Vu H.; Blum, William; Arellano, Martha L.; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L.; Kovacsovics, Tibor J.; Deininger, Michael W.; Zeidner, Joshua F.; Olin, Rebecca; Smith, Catherine C.; Foran, James M.; Schiller, Gary J.; Curran, Emily K.; Koenig, Kristin L.; Heerema, Nyla A.; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja Gullen; Rosenberg, Leonard; Druker, Brian J.; Levine, Ross L.; Burd, Amy; Yocum, Ashley Owen; Borate, Uma; Mims, Alice; Byrd, John C.; Madanat, Yazan F.
Immunophenotypic Markers CD7 and CD56 Improve Risk Stratification of Frontline Hypomethylating Agents plus Venetoclax in Newly Diagnosed AML

免疫表型标志物CD7和CD56可改善一线低甲基化药物联合Venetoclax在初诊AML中的风险分层

BLOOD
IF23.1
2024-11-050
PRE
Lachowiez, Curtis A.; Peters, Daniel; Fang, Jacob; Kaempf, Andy; Leonard, Jessica T.; Newell, Laura F.; Gandhi, Arpita; Meyers, Gabrielle; Hayes-Lattin, Brandon; Maziarz, Richard T.; Cook, Rachel J.; Traer, Elie; Swords, Ronan T.; Tyner, Jeffrey W.; Zeidner, Joshua F.; Pollyea, Daniel A.; Saultz, Jennifer N.
Outcomes and Survival in Newly Diagnosed, Older, Acute Myeloid Leukemia Patients from the Beat AML Master Trial in the Venetoclax/Azacitidine Age

新诊断、老年急性髓系白血病患者在Venetoclax/阿扎胞苷时代的Beat AML主试验中的结局与生存情况

BLOOD
IF23.1
2024-11-050
PRE
Borate, Uma; Huang, Ying; Li Welkie, Rina; Swords, Ronan T.; Traer, Elie; Stein, Eytan M.; Lin, Tara L.; Madanat, Yazan F.; Patel, Prapti A.; Collins, Robert H.; Baer, Maria R.; Duong, Vu H.; Blum, William; Arellano, Martha L.; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L.; Kovacsovics, Tibor J.; Deininger, Michael W.; Zeidner, Joshua F.; Olin, Rebecca; Smith, Catherine C.; Foran, James M.; Schiller, Gary J.; Curran, Emily K.; Koenig, Kristin L.; Heerema, Nyla A.; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja Gullen; Druker, Brian J.; Levine, Ross L.; Burd, Amy; Rossenber, Leohard; Yocum, Ashley Owen; Mims, Alice; Byrd, John C.
Phase 1 Trial Testing the Novel Combination Therapy of Entrectinib and ASTX727 in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia Patients

I期临床试验：评估Entrectinib与ASTX727新型联合疗法在TP53突变复发/难治性急性髓系白血病患者中的疗效

BLOOD
IF23.1
2024-11-050
PRE
Tognon, Cristina; Mishra, Shikha; Kaempf, Andy; Park, Byung; Joshi, Sunil K.; Huang, Ariane; Kurtz, Stephen E.; Sax, Luca; Eide, Christopher A.; Johnson, Kara; Mahoney, Rachel; Lue, Michael James; Tong, Nicole; Guiducci, Lisa; Willians, Tara Lundberg; Solanki, Emma Indira; Cook, Rachel J.; Leonard, Jessica T.; Lachowiez, Curtis A.; Meyers, Gabrielle; Saultz, Jennifer N.; Traer, Elie; Tyner, Jeffrey W.; Borate, Uma; Swords, Ronan T.
NCAM1 (CD56) As a Predictor of Response to Standard Intensive Induction in Newly Diagnosed Acute Myeloid Leukemia

NCAM1 (CD56) 作为新诊断急性髓系白血病对标准强化诱导治疗的应答预测指标

BLOOD
IF23.1
2024-11-050
PRE
Saultz, Jennifer N.; Rai, Manoj; Kaempf, Andy; Bastola, Sanjog; Cho, Hyun; Long, Nicola; Lachowiez, Curtis A.; Meyers, Gabrielle; Leonard, Jessica T.; Gandhi, Arpita; Newell, Laura F.; Hayes-Lattin, Brandon; Maziarz, Richard T.; Cook, Rachel J.; Traer, Elie; Swords, Ronan T.; Tyner, Jeffrey W.
Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy

Beat-aml 2024 ELN-对新诊断AML的老年人进行低强度治疗的风险分层

BLOOD ADVANCES
IF7.1
2024-10-102
OAAI
Hoff, Fieke W.; Blum, William G.; Huang, Ying; Li Welkie, Rina; Swords, Ronan T.; Traer, Elie; Stein, Eytan M.; Lin, Tara L.; Archer, Kellie J.; Patel, Prapti A.; Collins, Robert H.; Baer, Maria R.; Duong, Vu H.; Arellano, Martha L.; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L.; Kovacsovics, Tibor; Deininger, Michael W.; Zeidner, Joshua F.; Olin, Rebecca L.; Smith, Catherine C.; Foran, James M.; Schiller, Gary J.; Curran, Emily K.; Koenig, Kristin L.; Heerema, Nyla A.; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G.; Rosenberg, Leonard; Druker, Brian J.; Levine, Ross L.; Burd, Amy; Yocum, Ashley O.; Borate, Uma M.; Mims, Alice S.; Byrd, John C.; Madanat, Yazan F.
Proteogenomic and metabolomic characterization of acute myeloid leukemia
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Chu, Alec; Hsiao, Yi; Deng, Yamei; Wang, Chenwei; Kyle, Jennifer; Dou, Yongchao; Pino, James C.; Posso, Camilo; Henry, Leanne; Chen, Lijun; Li, Ginny Xiaohe; Lih, Tung-Shing Mamie; Geffen, Yifat; Yu, Fengchao; Ding, Li; Omenn, Gil; Kumar, Chandan; Dhanasekaran, Saravana M.; Traer, Elie; Tyner, Jeffrey W.; Zhang, Hui; Liu, Tao; Gosline, Sara; Zhang, Bing; Chinnaiyan, Arul; Nesvizhskii, Alexey I.; Cieslik, Marcin
Mapping the proteogenomic landscape enables prediction of drug response in acute leukemia
CELL REPORTS MEDICINE
IF10.6
2024-01-013
OAAI
Pino, James C.; Posso, Camilo; Joshi, Sunil K.; Nestor, Michael; Moon, Jamie; Hansen, Joshua R.; Hutchinson-Bunch, Chelsea; Gritsenko, Marina A.; Weitz, Karl K.; Watanabe-Smith, Kevin; Long, Nicola; Mcdermott, Jason E.; Druker, Brian J.; Liu, Tao; Tyner, Jeffrey W.; Agarwal, Anupriya; Traer, Elie; Piehowski, Paul D.; Tognon, Cristina E.; Rodland, Karin D.; Gosline, Sara J. C.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes

针对TIM-3抗体的新型免疫疗法sabatolimab (MBG453) 与地西他滨或阿扎胞苷联合治疗高危或极高危骨髓增生异常综合征的Ib期研究

AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2023-11-2212
OAAI
Brunner, Andrew M.; Esteve, Jordi; Porkka, Kimmo; Knapper, Steve; Traer, Elie; Scholl, Sebastian; Garcia-Manero, Guillermo; Vey, Norbert; Wermke, Martin; Janssen, Jeroen J. W. M.; Narayan, Rupa; Fleming, Shaun; Loo, Sun; Tovar, Natalia; Kontro, Mika; Ottmann, Oliver G.; Naidu, Purushotham; Sun, Haiying; Han, May; White, Roisin; Zhang, Na; Mohammed, Anisa; Sabatos-Peyton, Catherine A.; Steensma, David P.; Rinne, Mikael L.; Borate, Uma M.; Wei, Andrew H.
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates
BLOOD ADVANCES
IF7.1
2023-05-258
OAAI
Saliba, Antoine N.; Kaufmann, Scott H.; Stein, Eytan M.; Patel, Prapti A.; Baer, Maria R.; Stock, Wendy; Deininger, Michael; Blum, William; Schiller, Gary J.; Olin, Rebecca L.; Litzow, Mark R.; Lin, Tara L.; Ball, Brian J.; Boyiadzis, Michael M.; Traer, Elie; Odenike, Olatoyosi; Arellano, Martha L.; Walker, Alison; Duong, Vu H.; Kovacsovics, Tibor; Collins, Robert H.; Shoben, Abigail B.; Heerema, Nyla A.; Foster, Matthew C.; Peterson, Kevin L.; Schneider, Paula A.; Martycz, Molly; Gana, Theophilus J.; Rosenberg, Leonard; Marcus, Sonja; Yocum, Ashley O.; Chen, Timothy; Stefanos, Mona; Mims, Alice S.; Borate, Uma; Burd, Amy; Druker, Brian J.; Levine, Ross L.; Byrd, John C.; Foran, James M.

研究方向

暂未获取到该数据
B
Brian Druker
H 指数:135论文数:2,590被引数:9.5万
J
Jeffrey Tyner
H 指数:70论文数:2,134被引数:2.3万
R
Ronan Swords
H 指数:36论文数:296被引数:9,496
J
Jessica Leonard
H 指数:20论文数:194被引数:3,078
S
Sunil K. Joshi
H 指数:31论文数:183被引数:4,422
M
Michael W. Deininger
H 指数:98论文数:864被引数:4.8万
R
Robert H. Collins
H 指数:54论文数:348被引数:1.6万
C
Cristina E. Tognon
H 指数:38论文数:227被引数:1.0万
A
Anupriya Agarwal
H 指数:39论文数:302被引数:9,363
J
Jennifer Dunlap
H 指数:21论文数:66被引数:1,507